Demirkol, D. Et Al. 2012. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?. CRITICAL CARE , vol.16, no.2 .

Demirkol, D., Yildizdas, D., BAYRAKCİ, B., KARAPINAR, B., Kendirli, T., Koroglu, T. F., ... DURSUN, O.(2012). Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?. CRITICAL CARE , vol.16, no.2.

Demirkol, Demet Et Al. "Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?," CRITICAL CARE , vol.16, no.2, 2012

Demirkol, Demet Et Al. "Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?." CRITICAL CARE , vol.16, no.2, 2012

Demirkol, D. Et Al. (2012) . "Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?." CRITICAL CARE , vol.16, no.2.

@article{article, author={Demet Demirkol Et Al. }, title={Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?}, journal={CRITICAL CARE}, year=2012}